Hyperlipidemia; Mixed Clinical Trial
Official title:
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
| Verified date | October 2021 |
| Source | Misr University for Science and Technology |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.
| Status | Active, not recruiting |
| Enrollment | 3 |
| Est. completion date | March 20, 2022 |
| Est. primary completion date | July 1, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility | Inclusion Criteria: - Patients of dyslipidemia with high triglyceride level (200 to 499 mg/100 ml). - Total cholesterol level more than 200 mg/100 ml - Male and female - Age 35 - 70 years Exclusion Criteria: - - Hypersensitivity of drugs - Liver toxicity - -Patients suffering from renal dysfunction |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Misr University for science and technology | Giza |
| Lead Sponsor | Collaborator |
|---|---|
| Misr University for Science and Technology |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Reduction of Total cholesterol | reduction of LDL | 3 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03274089 -
Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk
|
N/A |